Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study
| dc.contributor.author | Boris Michel | |
| dc.contributor.author | Miriam Navarro | |
| dc.contributor.author | Michael Pritsch | |
| dc.contributor.author | Jeremy Douglas Du Plessis | |
| dc.contributor.author | Jonathan P. Shock | |
| dc.contributor.author | Eva‐Maria Schwienhorst-Stich | |
| dc.contributor.author | Janina Zirkel | |
| dc.contributor.author | Hanna Schrader | |
| dc.contributor.author | Claudia Saavedra Irala | |
| dc.contributor.author | Gonzalo Rubilar | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T16:03:44Z | |
| dc.date.available | 2026-03-22T16:03:44Z | |
| dc.date.issued | 2022 | |
| dc.description | Citaciones: 2 | |
| dc.description.abstract | Social determinants of health, the unavailability of treatment and a wonder drug image might contribute to the phenomenon of vet-IVM. | |
| dc.identifier.doi | 10.1136/bmjopen-2021-058572 | |
| dc.identifier.uri | https://doi.org/10.1136/bmjopen-2021-058572 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/56016 | |
| dc.language.iso | en | |
| dc.publisher | BMJ | |
| dc.relation.ispartof | BMJ Open | |
| dc.source | Centro de Información y Desarrollo de la Mujer | |
| dc.subject | Medicine | |
| dc.subject | Pandemic | |
| dc.subject | Focus group | |
| dc.subject | Disease | |
| dc.subject | Ivermectin | |
| dc.subject | Chagas disease | |
| dc.subject | Public health | |
| dc.subject | Biostatistics | |
| dc.subject | Qualitative research | |
| dc.subject | Environmental health | |
| dc.title | Understanding the widespread use of veterinary ivermectin for Chagas disease, underlying factors and implications for the COVID-19 pandemic: a convergent mixed-methods study | |
| dc.type | article |